The Cooper Companies, Inc. $COO Shares Sold by CW Advisors LLC

CW Advisors LLC reduced its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 11.3% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 140,687 shares of the medical device company’s stock after selling 17,937 shares during the period. CW Advisors LLC owned approximately 0.07% of Cooper Companies worth $10,011,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in COO. Cetera Investment Advisers grew its holdings in shares of Cooper Companies by 1.7% during the first quarter. Cetera Investment Advisers now owns 24,461 shares of the medical device company’s stock worth $2,063,000 after buying an additional 412 shares during the last quarter. LPL Financial LLC raised its stake in Cooper Companies by 4.7% during the 1st quarter. LPL Financial LLC now owns 148,261 shares of the medical device company’s stock valued at $12,506,000 after acquiring an additional 6,657 shares during the last quarter. New Age Alpha Advisors LLC lifted its position in Cooper Companies by 3,223.5% during the 1st quarter. New Age Alpha Advisors LLC now owns 13,593 shares of the medical device company’s stock worth $1,147,000 after acquiring an additional 13,184 shares during the period. Goldman Sachs Group Inc. grew its stake in shares of Cooper Companies by 17.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock valued at $399,340,000 after purchasing an additional 686,751 shares during the last quarter. Finally, ASR Vermogensbeheer N.V. acquired a new position in shares of Cooper Companies in the first quarter valued at approximately $304,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

NASDAQ:COO opened at $77.03 on Friday. The firm’s fifty day simple moving average is $72.01 and its 200-day simple moving average is $71.74. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The stock has a market cap of $15.31 billion, a PE ratio of 37.95, a price-to-earnings-growth ratio of 1.87 and a beta of 1.05. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $104.47.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the previous year, the firm earned $1.04 earnings per share. The firm’s revenue was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its board has approved a share buyback program on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to purchase up to 15.4% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Analysts Set New Price Targets

Several brokerages recently weighed in on COO. Robert W. Baird decreased their price target on Cooper Companies from $97.00 to $85.00 and set an “outperform” rating for the company in a report on Thursday, August 28th. Needham & Company LLC restated a “buy” rating and issued a $94.00 target price on shares of Cooper Companies in a research note on Thursday, August 28th. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $72.00 target price on shares of Cooper Companies in a report on Thursday, November 13th. Piper Sandler cut their price target on shares of Cooper Companies from $105.00 to $83.00 and set an “overweight” rating for the company in a report on Thursday, August 28th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Cooper Companies in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $84.77.

Insider Activity at Cooper Companies

In other news, Director Lawrence Erik Kurzius purchased 2,000 shares of the stock in a transaction that occurred on Monday, September 29th. The shares were acquired at an average price of $68.39 per share, for a total transaction of $136,780.00. Following the acquisition, the director directly owned 5,777 shares in the company, valued at approximately $395,089.03. The trade was a 52.95% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.98% of the stock is owned by company insiders.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.